Full Text View
Tabular View
No Study Results Posted
Related Studies
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
This study is currently recruiting participants.
Verified March 2014 by Merck Sharp & Dohme Corp.
Study NCT01170650   Information provided by Merck Sharp & Dohme Corp.

First Received on July 7, 2010.   Last Updated on March 12, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial